{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:05:25Z","timestamp":1761764725845},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.ejca.2006.03.013","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T13:58:40Z","timestamp":1150034320000},"page":"1775-1779","source":"Crossref","is-referenced-by-count":36,"title":["Activity of thalidomide in patients with platinum-refractory germ-cell tumours"],"prefix":"10.1016","volume":"42","author":[{"given":"O.","family":"Rick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Siegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2006.03.013_bib1","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199707243370406","article-title":"Testicular germ-cell cancer","volume":"337","author":"Bosl","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2006.03.013_bib2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1023\/A:1008286305312","article-title":"Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology","volume":"8","author":"Pont","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2006.03.013_bib3","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0959-8049(03)00003-0","article-title":"Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support","volume":"39","author":"Kollmannsberger","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2006.03.013_bib4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1200\/JCO.2000.18.6.1181","article-title":"Results of treatment after relapse from high-dose chemotherapy in germ cell tumors","volume":"18","author":"Porcu","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.03.013_bib5","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1200\/JCO.2004.10.127","article-title":"Thalidomide: current role in the treatment of non-plasma cell malignancies","volume":"22","author":"Kumar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.03.013_bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1323::AID-CNCR15>3.0.CO;2-G","article-title":"Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease","volume":"85","author":"Fukuda","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2006.03.013_bib7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/annonc\/mdg416","article-title":"Marked increase of the growth factors pleiotrophin and fibroblast growth factor-2 in serum of testicular cancer patients","volume":"14","author":"Aigner","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2006.03.013_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.2001.19.1.81","article-title":"Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer","volume":"19","author":"Rick","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2006.03.013_bib9","unstructured":"National Cancer Institute. Common Toxicity Criteria v2.0 (CTC). Updated 18th August 1999. Available from http:\/\/ctep.cancer.gov."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906003388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804906003388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T22:53:42Z","timestamp":1547592822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804906003388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0959804906003388"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2006.03.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}